Solar erythema is the typical sunburn that we suffer when we are subjected to ultraviolet radiation for a long time. In general, the most intense symptoms appear in the first 24 hours and then begin to decline.
What is known as solar erythema is a set of entities with different severity. There are slight lesions, with only a peeling of the superficial layer of the epidermis. However, at other times, the burn sheds a patch of skin and causes blisters.
In either situation, the affected area becomes red from blood congestion. There is not always inflammation, but it can happen that the flow of fluids in the tissues increases their volume.
As we have said, this solar erythema comes from the action of the sun’s ultraviolet rays. Although there are different wavelengths in the sun’s rays, the radiations that most affect the skin are UVB and UVA.
UVA radiation is very penetrating, and can reach the dermis, which is below the epidermis. Its negative effect is manifested in the long term. Accelerates cellular aging and favors the development of skin cancer.
On the other hand, UVB radiation is the direct culprit of solar erythema. The skin tans and burns from this radiation. It is also capable of altering cells, turning them cancerous. Therefore, both radiations are an oncological risk factor.
Risk groups for solar erythema
We can all suffer from solar erythema if we expose ourselves inappropriately to the sun’s radiation, at times that are not recommended and without protection. In any case, certain population groups are more prone to these burns; among them are the following:
Those who have to work, yes or yes, in homeless environments, at noon.
People with a very light complexion.
Those who carry out water sports or mountain activities, since the reflection of the water and the snow is capable of burning with the same intensity as direct light.
Inhabitants of tropical areas, where the direction of the sun is more perpendicular to the earth and the radiation schedule is longer.
Patients medicated with some antibiotics, such as doxycycline.
Chronic patients with autoimmune diseases with dermal involvement, such as lupus.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy